ClassID:

109811

C12N2710/16243 - CPC Classification

Classification description:

dsDNA viruses; Details; Herpesviridae; Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Recent Application in this class:
#1
20260055165
2026-02-26

MONOCLONAL ANTIBODY ISOLATION

#2
20240034999
2024-02-01

IMPROVED REPROGRAMMING, MAINTENANCE AND PRESERVATION FOR INDUCED PLURIPOTENT STEM CELLS

#3
20190263883
2019-08-29

METHOD FOR AUGMENTING VISION IN PERSONS SUFFERING FROM PHOTORECEPTOR CELL DEGENERATION

#4
20160022841
2016-01-28

Method for augmenting vision in persons suffering from photoreceptor cell degeneration

#5
20160010113
2016-01-14

COMPOSITIONS AND METHODS FOR ENGINEERING CELLS

#6
20140322255
2014-10-30

Second generation virus-like particles (VLP) from Epstein-Barr viruses for vaccination purposes

#7
20130040304
2013-02-14

Compositions and Methods for Engineering Cells

#8
20120058562
2012-03-08

Reprogramming immortalized B-cells to induced pluripotent stem cells

#9
20110263001
2011-10-27

Compositions and Methods for Engineering Cells

#10
20100048670
2010-02-25

Stable and long-lasting siRNA expression vectors and the applications thereof

#11
20090136542
2009-05-28

Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site

#12
20090098161
2009-04-16

Method of making immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane

#13
20090098160
2009-04-16

Method of inducing an immune response in a host by administering immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane

#14
20090028890
2009-01-29

Immunizing compositions comprising recombinant attenuated self-replicating viral RNA replicons encoding an epitope obtained from the HIV-1 matrix protein myrstate binding site

#15
20080145894
2008-06-19

Methods and materials for expression of a recombinant protein

#16
20080124762
2008-05-29

Methods and Materials for Expression of a Recombinant Protein

#17
20060251620
2006-11-09

Inducible alphaviral/orip based gene expression system

#18
20060194203
2006-08-31

Packing cell system for eb virus vector

#19
20060121604
2006-06-08

Methods and materials for expression of a recombinant protein

#20
20060051739
2006-03-09

Methods and composition for visualizing and interfering with chromosomal tethering of extrachromosomal molecules

#21
20050260564
2005-11-24

Non-cytotoxic oriP replicon

#22
20050227317
2005-10-13

Mammalian expression system

#23
20050214318
2005-09-29

Immunogenic composition and method of developing a vaccine based on fusion protein

#24
20050214317
2005-09-29

Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site

#25
20050208022
2005-09-22

Method for augmenting vision in persons suffering from photoreceptor cell degeneration

#26
20050112143
2005-05-26

Immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) devoid of CD55 and CD59 in the viral membrane

#27
20050112140
2005-05-26

Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide

#28
20050112139
2005-05-26

Immunogenic composition and method of developing a vaccine based on factor H binding sites

#29
20050106733
2005-05-19

Double-stranded cyclic dna capable of proliferating as a bacterial e coli chromosome